Imbruvica

Indicated For

CLL, MCL, WM

About This Medication

# myAbbVie Assist Patient Guide: How to Get Imbruvica (ibrutinib) at Low or No Cost Imbruvica (ibrutinib) is a targeted therapy used to treat certain blood cancers like chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström's macroglobulinemia. The **myAbbVie Assist** program, run by AbbVie and Janssen, offers this medication **free** to eligible uninsured or underinsured patients facing financial hardship.[1][3] ## About Imbruvica (ibrutinib) **Imbruvica** is a prescription medicine that works by blocking a protein called Bruton's tyrosine kinase (BTK), which helps cancer cells grow. It's available as capsules, tablets, or oral suspension and is taken once daily at the same time each day. Your doctor will monitor your heart function before and during treatment, as it can cause heart rhythm problems, bleeding, infections, or high blood pressure. Always follow your healthcare provider's instructions exactly. Common side effects include diarrhea, fatigue, bruising, and nausea—report serious symptoms like irregular heartbeat, shortness of breath, or severe bleeding immediately.[7] This guide explains how **myAbbVie Assist** can help you access Imbruvica at no cost if you qualify. The program is free to join, with no co-pays or shipping fees for approved patients.[1][3] ## Who Qualifies for myAbbVie Assist? Qualification is based on financial need, residency, insurance status, and lack of coverage from government programs. Key criteria include: - **U.S. residency**: You must live in the United States. - **Financial hardship**: Income-based eligibility for uninsured or underinsured patients. Specific Federal Poverty Level (FPL) thresholds aren't publicly fixed but are assessed individually—often around or below 400-500% FPL, with special rules for Medicare patients below 150% FPL who may qualify for Extra Help.[1][9] - **No government insurance**: Not eligible if on Medicare Part D, Medicaid, or similar programs as primary coverage, though some Medicare patients can enroll with restrictions.[1][9] - **Prescription valid**: Must have a prescription for Imbruvica from a licensed U.S. healthcare provider.[5] The program evaluates your full situation; even if income is slightly above typical thresholds, other factors like out-of-pocket costs may qualify you.[2] ## Income Eligibility Breakdown myAbbVie Assist uses income verification to determine eligibility. They may check electronically via Fair Credit Reporting Act consent or request documents like tax returns. Here's a general guide based on program practices (exact thresholds vary yearly and by household; call for personalized assessment): | Household Size | Estimated Max Income (400% FPL example, 2026) | Notes | |---------------|-----------------------------------------------|-------| | 1 (Individual) | ~$60,000 | Assessed case-by-case[2] | | 2 (Couple) | ~$81,000 | Includes dependents[1] | | 3 | ~$102,000 | Proof required[2] | | 4 | ~$123,000 | Higher for larger families | **Notes**: These are illustrative based on common PAP standards; myAbbVie Assist confirms via application. Medicare patients under 150% FPL (~$22,590 individual) may get Extra Help first.[9] Provide recent tax returns or pay stubs for accuracy.[1][2] ## Insurance Requirements - **Uninsured or underinsured**: Ideal for those without insurance or with high co-pays/deductibles. - **Exclusions**: Cannot use if primarily covered by Medicare, Medicaid, VA, Tricare, or state programs. Medicare Part D enrollees must not seek reimbursement or True Out-of-Pocket (TrOOP) credit for program meds.[1][9] - **Commercial insurance**: May qualify if costs are unaffordable, but disclose all plans. Attach front/back copies of insurance cards. The program contacts your provider for details.[2][5] ## Step-by-Step Application Process Applying is straightforward and free. Multiple methods available: online, phone, or paper form.[1][2] 1. **Gather Documents**: Proof of income (tax return, W-2, pay stubs), residency (utility bill, lease), prescription, insurance cards (if any).[1][2] 2. **Choose Method**: - **Online**: Visit AbbVie.com/PatientAccessSupport, create account, enter info, upload docs. Program contacts your doctor.[2] - **Phone**: Call **(800) 222-6885** for help or paper form.[1] - **Paper**: Download from site, complete with doctor, mail.[1] 3. **Doctor's Role**: Provider completes clinical section, signs, provides prescription.[2][5] 4. **Sign & Submit**: Consent to terms, HIPAA release, income check.[1][9] 5. **Wait for Review**: Get email/text updates if signed up.[2] ## Timeline and Delivery Processing time varies (typically 2-4 weeks), depending on document completeness. Once approved, medication ships free to your home or doctor's office. Refills scheduled online via your account; reauthorization needed periodically (annual or per calendar year for Medicare).[1][2] Track status by calling (800) 222-6885. ## Alternatives if Denied or No Biosimilars No biosimilar alternatives for Imbruvica currently.[program data] If denied: - Appeal with updated docs. - Explore Imbruvica By Your Side copay card for insured (call 1-844-585-4135).[7] - Check Medicare Extra Help (1-800-MEDICARE).[9] - State programs, NeedyMeds.org, or PAN Foundation. - Doctor may sample or prior auth with insurer. ## Important Disclaimer This guide is for informational purposes only and based on publicly available data as of 2024-2026. Program rules can change; eligibility not guaranteed. Consult myAbbVie Assist at (800) 222-6885 or your doctor. Not medical/financial advice. Notify program of changes in income/insurance. Medicare rules strictly apply—no double-dipping benefits.[1][2][9] (Word count: 1028)

Program information last verified: March 30, 2026